Initially, FVIII replacement was sourced from whole blood and plasma, but advances in biotechnology led to the development of ...

TOKYO- 18 April 2025 – CSL Behring K.K. (Headquarters ... ANDEMBRY® uniquely inhibits the plasma protein, FXIIa. When FXII is activated, it initiates the cascade of events leading to edema formation.

The research explores the use of plasma-assisted surface modification techniques to eliminate nanometer-scale surface asperities. By combining molecular dynamics (MD) simulations with experimental ...

EQS-News: Viromed Medical AG / Key word(s): Alliance/Contract Viromed Medical AG: Exclusive distribution partnership with AMAMUS Vet for the cold plasma medical device ViroCAP® VET for veterinary ...

This is a problem that researchers within The Coordinated Science Laboratory (CSL) through The Grainger College of Engineering at the University of Illinois Urbana-Champaign collaborated with other ...

Last week, I was at Intel’s Vision conference at the Virgin Hotel in Las Vegas. While the venue was a bit problematic, the content was solid and showcased an empowered Intel that now needs to ...